New patent for Azurity drug EPRONTIA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for EPRONTIA
Annual Drug Patent Expirations for EPRONTIA

Eprontia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

EPRONTIA drug price trends.

The generic ingredient in EPRONTIA is topiramate. One supplier is listed for this compound. Additional details are available on the topiramate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top